This report contains market size and forecasts of Mild-to-Moderate Atopic Dermatitis Treatment in Global, including the following market information:
Global Mild-to-Moderate Atopic Dermatitis Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Mild-to-Moderate Atopic Dermatitis Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Mild-to-Moderate Atopic Dermatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mild-to-Moderate Atopic Dermatitis Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Mild-to-Moderate Atopic Dermatitis Treatment Market Segment Percentages, By Type, 2020 (%)
Radiation Treatment
Drug Treatment
China Mild-to-Moderate Atopic Dermatitis Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Mild-to-Moderate Atopic Dermatitis Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Mild-to-Moderate Atopic Dermatitis Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Mild-to-Moderate Atopic Dermatitis Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Mild-to-Moderate Atopic Dermatitis Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Mild-to-Moderate Atopic Dermatitis Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Bausch Health
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Mild-to-Moderate Atopic Dermatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mild-to-Moderate Atopic Dermatitis Treatment Overall Market Size
2.1 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size: 2021 VS 2027
2.2 Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mild-to-Moderate Atopic Dermatitis Treatment Players in Global Market
3.2 Top Global Mild-to-Moderate Atopic Dermatitis Treatment Companies Ranked by Revenue
3.3 Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Mild-to-Moderate Atopic Dermatitis Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Mild-to-Moderate Atopic Dermatitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mild-to-Moderate Atopic Dermatitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Mild-to-Moderate Atopic Dermatitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Mild-to-Moderate Atopic Dermatitis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size Markets, 2021 & 2027
4.1.2 Radiation Treatment
4.1.3 Drug Treatment
4.2 By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2021
4.2.2 By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2022-2027
4.2.3 By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2021
5.2.2 By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2022-2027
5.2.3 By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2021 & 2027
6.2 By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2021
6.2.2 By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2022-2027
6.2.3 By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027
6.3.2 US Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.3.3 Canada Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.3.4 Mexico Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027
6.4.2 Germany Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.3 France Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.4 U.K. Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.5 Italy Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.6 Russia Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.4.8 Benelux Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027
6.5.2 China Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.5.3 Japan Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.5.4 South Korea Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.5.6 India Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027
6.6.2 Brazil Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.6.3 Argentina Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027
6.7.2 Turkey Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.7.3 Israel Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
6.7.5 UAE Mild-to-Moderate Atopic Dermatitis Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.1.4 Novartis Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.2.4 Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.3.4 Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.3.5 Sanofi Key News
7.4 Anacor Pharmaceuticals
7.4.1 Anacor Pharmaceuticals Corporate Summary
7.4.2 Anacor Pharmaceuticals Business Overview
7.4.3 Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.4.4 Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.4.5 Anacor Pharmaceuticals Key News
7.5 Astellas Pharma
7.5.1 Astellas Pharma Corporate Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.5.4 Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.5.5 Astellas Pharma Key News
7.6 Meda Pharmaceuticals
7.6.1 Meda Pharmaceuticals Corporate Summary
7.6.2 Meda Pharmaceuticals Business Overview
7.6.3 Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.6.4 Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.6.5 Meda Pharmaceuticals Key News
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Corporate Summary
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.4.4 Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.7.5 Regeneron Pharmaceuticals Key News
7.8 Bausch Health
7.8.1 Bausch Health Corporate Summary
7.8.2 Bausch Health Business Overview
7.8.3 Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Major Product Offerings
7.8.4 Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (2016-2021)
7.8.5 Bausch Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Mild-to-Moderate Atopic Dermatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Mild-to-Moderate Atopic Dermatitis Treatment Market Drivers in Global Market
Table 3. Mild-to-Moderate Atopic Dermatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Mild-to-Moderate Atopic Dermatitis Treatment in Global Market
Table 5. Top Mild-to-Moderate Atopic Dermatitis Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Mild-to-Moderate Atopic Dermatitis Treatment Product Type
Table 9. List of Global Tier 1 Mild-to-Moderate Atopic Dermatitis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mild-to-Moderate Atopic Dermatitis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Mild-to-Moderate Atopic Dermatitis Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Novartis Corporate Summary
Table 31. Novartis Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 32. Novartis Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 35. Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 38. Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Anacor Pharmaceuticals Corporate Summary
Table 40. Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 41. Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Astellas Pharma Corporate Summary
Table 43. Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 44. Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Meda Pharmaceuticals Corporate Summary
Table 46. Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 47. Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Regeneron Pharmaceuticals Corporate Summary
Table 49. Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 50. Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Bausch Health Corporate Summary
Table 52. Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Product Offerings
Table 53. Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Mild-to-Moderate Atopic Dermatitis Treatment Segment by Type
Figure 2. Mild-to-Moderate Atopic Dermatitis Treatment Segment by Application
Figure 3. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Mild-to-Moderate Atopic Dermatitis Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mild-to-Moderate Atopic Dermatitis Treatment Revenue in 2020
Figure 8. By Type - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 12. US Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 24. China Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Mild-to-Moderate Atopic Dermatitis Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Mild-to-Moderate Atopic Dermatitis Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Novartis Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Sanofi Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Anacor Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Astellas Pharma Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Meda Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Regeneron Pharmaceuticals Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Bausch Health Mild-to-Moderate Atopic Dermatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Novartis
Pfizer
Sanofi
Anacor Pharmaceuticals
Astellas Pharma
Meda Pharmaceuticals
Regeneron Pharmaceuticals
Bausch Health